GUIDED THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Guided Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • Guided Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending August 10, 2024 was 56.6M shares, a 10.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 56.6M +5.26M +10.3% Aug 10, 2024 10-Q 2024-08-14
Q1 2024 55.6M +5.11M +10.1% Mar 28, 2024 10-K 2024-03-28
Q3 2023 52.1M +3.52M +7.24% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 51.3M Aug 10, 2023 10-Q 2023-08-10
Q1 2023 50.5M +28.4M +129% Mar 27, 2023 10-K 2023-03-30
Q3 2022 48.6M +34.9M +256% Nov 14, 2022 10-Q 2022-11-14
Q1 2022 22.1M +8.88M +67.4% Mar 15, 2022 10-K 2022-03-30
Q3 2021 13.6M +537K +4.1% Nov 10, 2021 10-Q 2021-11-15
Q2 2021 13.3M +1.03M +8.42% Aug 10, 2021 10-Q 2021-08-18
Q1 2021 13.2M +1.87M +16.6% Apr 5, 2021 10-K 2021-04-07
Q3 2020 13.1M Nov 1, 2020 10-Q/A 2020-11-05
Q2 2020 12.3M +8.95M +269% Jul 3, 2020 10-Q 2020-07-07
Q1 2020 11.3M +7.99M +241% Apr 7, 2020 10-K 2020-04-20
Q4 2019 3.32M Feb 7, 2020 10-Q 2020-02-11
Q2 2019 3.32M -292M -98.9% Jun 17, 2019 10-Q 2019-07-11
Q1 2019 3.32M -141M -97.7% Apr 15, 2019 10-K 2019-05-08
Q3 2018 479M +460M +2364% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 295M +292M +8106% Aug 1, 2018 10-Q 2018-08-14
Q1 2018 144M +143M +12924% Apr 8, 2018 10-K/A 2018-04-20
Q3 2017 19.5M Nov 7, 2017 10-Q 2017-11-20
Q2 2017 3.6M -150M -97.7% Aug 7, 2017 10-Q 2017-08-18
Q1 2017 1.11M -2.05M -65% Mar 6, 2017 10-K 2017-03-22
Q4 2016 571K Nov 30, 2016 10-Q 2016-12-05
Q2 2016 154M +40.4M +35.6% Aug 11, 2016 10-Q 2016-08-17
Q1 2016 3.15M -94M -96.8% Mar 7, 2016 10-K 2016-03-15
Q3 2015 164M +83.8M +105% Oct 30, 2015 10-Q 2015-11-12
Q2 2015 114M +38M +50.4% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 97.2M +25.5M +35.5% Mar 16, 2015 10-K 2015-03-25
Q3 2014 79.9M +13.6M +20.5% Nov 4, 2014 10-Q 2014-11-12
Q2 2014 75.5M Aug 9, 2014 10-Q 2014-08-13
Q1 2014 71.7M +6.9M +10.6% Mar 20, 2014 10-K 2014-03-26
Q3 2013 66.3M +4.12M +6.62% Nov 11, 2013 10-Q 2013-11-13
Q1 2013 64.8M +12.4M +23.6% Mar 26, 2013 10-K 2013-03-27
Q3 2012 62.2M +13.6M +28% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 61.3M Aug 7, 2012 10-Q/A 2012-08-24
Q1 2012 52.4M Mar 6, 2012 10-K 2012-03-28
Q3 2011 48.6M Aug 15, 2011 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.